[P13] Poster Session 13　Genitourinary Cancer（Urinary tract Cancer）

[P13-1] KEYNOTE-905/EV-303: Perioperative Pembrolizumab or Pembrolizumab + Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

^○Andrea Necchi¹, Matthew D. Galsky², Neal D. Shore³, Elizabeth Plimack⁴, Calvin Jin⁵, Tammy Hennika⁵, Blanca Homet Moreno⁵, J. Alfred Witjes⁶ (1.IRCCS San Raffaele Hospital and Scientific Institute, 2.Icahn School of Medicine at Mount Sinai, 3.Carolina Urologic Research Center, 4.Fox Chase Cancer Center, 5.Merck & Co., Inc., 6.Radboud University)